VAERS reports by lot

Merck Pneumococcal lot K008409: VAERS reports

65 VAERS reports list lot K008409 as a Merck Pneumococcal vaccine, received between 2014-11-07 and 2025-04-20. Data: VAERS public files through 28 May 2026 (site extract 2026-10-28).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
65
Reports
28%
Marked serious
0
With a death outcome
21
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction9151%
General / Systemic (non-local)2514%
Musculoskeletal148%
Cardiac / Cardiovascular127%
Allergic / Anaphylactic127%
Dermatological (non-injection-site)127%
Gastrointestinal53%
Neurological42%
Respiratory42%
Thrombotic / Hematological11%

Where reports came from

U.S. state of the reporter, where given (top 12).

StateReports
Texas9
Pennsylvania9
Maryland4
New York4
Massachusetts4
South Carolina3
Michigan3
Ohio2
California2
Arizona2
Montana2
Florida2

Reports by month received

MonthReportsBar
2014-117
2014-127
2015-015
2015-027
2015-032
2015-043
2015-051
2015-066
2015-071
2015-095
2015-101
2015-111
2015-122
2016-011
2016-021
2016-032
2016-041
2016-051
2016-071
2016-119
2025-041

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Nearby Merck Pneumococcal lots (A–Z): K007822 · K007824 · K007826 · K008410 · K008927 · K009105

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-10-28 18:08 UTC. Not medical advice. Report errors via contact.